Cargando...
Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab
PURPOSE: To report the 12-month outcomes of a patient switching from intravitreal ranibizumab to aflibercept for choroidal neovascularization (CNV) associated with angioid streaks (AS). RESULTS: A 42-year-old Caucasian female with CNV associated with AS underwent intensive treatment with ranibizumab...
Guardado en:
| Publicado en: | Int Med Case Rep J |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6149836/ https://ncbi.nlm.nih.gov/pubmed/30271222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IMCRJ.S166473 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|